ãã€ãªãã¯ãããžãŒäŒæ¥ã§ããEvelo Biosciences, Inc.ã¯ãççæ§çŸæ£ããã³ããã®æ²»çã®ããã®çµå£çç©è£œå€ã®çºèŠãšéçºãè¡ã£ãŠããŸããå瀟ã¯ãççæ§çŸæ£ã®æ²»çã®ããã®å
šåŸ®çç©åè£ã§ããEDP1815ãéçºããŠããã也ç¬ãšã¢ãããŒæ§ç®èçã®æ²»çãããã³COVID-19ã«é¢é£ããéå°ççåå¿ã®èšåºéçºè©Šéšãè¡ã£ãŠããŸããå瀟ã¯ãŸããççæ§çŸæ£ã®æ²»çã®ããã®äžæŽ»åæ²»éšçšçµå£çç©è£œå€EDP1867ãççæ§çŸæ£ã®æ²»çã®ããã®çްèå€å°èæ²»éšçšçµå£çç©è£œå€EDP2939ãããã³è
«çåŠã®è£œååè£ã§ããEDP1908ã®éçºã«ãåãçµãã§ããŸããEvelo Biosciences, Inc.ã¯2014幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ¬ç€Ÿã眮ããŠããŸãã